Skip to main content
Tempus AILinkedIn

Tempus AI launches Real-Time Variant Tracker as a supplement to xM NeXT Personal Dx.

Source: Autobound Signal API · 97 signals tracked for Tempus AI · updated

Get Tempus AI's live signals in Claude or ChatGPT, or by API

AskWhat changed at Tempus AI this week? Use Autobound signals for tempus.com.

Source

LinkedInNov 12, 2026
likes
71
comments
0

Post

xM (NeXT Personal® Dx) is a key part of the patient care continuum, providing crucial information during surveillance and monitoring for early-stage disease and for IO treatment response monitoring for late-stage disease. Now available to support your clinical insights, Real-Time Variant Tracker™ is a supplemental part of xM (NeXT Personal® Dx) that tracks resistance and therapeutically targetable variants, including variants associated with NCCN guideline-recommended and FDA-approved therapies. Learn more: https://tempus.co/4iLchFR

linkedin.com/posts/tempusai_xm-next-personal-dx-is-a-key-part-of-the-...Read the full source

Extracted by Autobound

From the Signal API record
Signal
LinkedIn

What this signalsCompany posts often show what the team is pushing right now.

More LinkedIn signals at other companies

The full record

From the Signal API record

Topics and mentions

Tags

  • Medical Research
  • Pharmaceuticals

Initiatives

  • launch of Real-Time Variant Tracker

Extraction

Detected
Nov 12, 2026
signal_type
linkedin-post-company
signal_subtype
linkedinPost

Use this data

Get every LinkedIn signal for Tempus AI and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Tempus AI this week?”

  2. Send it to your own tools

    The Signal API returns LinkedIn signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full linkedin-post-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/ce3652a6-dc84-43f7-9555-4833d037cf66 returns this record as JSON. POST /v1/companies/enrich returns every signal for tempus.com.

{
  "signal_id": "ce3652a6-dc84-43f7-9555-4833d037cf66",
  "signal_type": "linkedin-post-company",
  "signal_subtype": "linkedinPost",
  "detected_at": "2026-11-12T18:21:44.33+00:00",
  "company": {
    "name": "Tempus AI",
    "domain": "tempus.com"
  },
  "data": {
    "tags": [
      "Medical Research",
      "Pharmaceuticals"
    ],
    "summary": "Tempus AI launches Real-Time Variant Tracker as a supplement to xM NeXT Personal Dx.",
    "post_url": "https://www.linkedin.com/posts/tempusai_xm-next-personal-dx-is-a-key-part-of-the-activity-7526710842306760704-d1Fc",
    "num_likes": 71,
    "post_text": "xM (NeXT Personal® Dx) is a key part of the patient care continuum, providing crucial information during surveillance and monitoring for early-stage disease and for IO treatment response monitoring for late-stage disease. \n\nNow available to support your clinical insights, Real-Time Variant Tracker™ is a supplemental part of xM (NeXT Personal® Dx) that tracks resistance and therapeutically targetable variants, including variants associated with NCCN guideline-recommended and FDA-approved therapies.\n\nLearn more: https://tempus.co/4iLchFR",
    "initiatives": [
      {
        "topic": "launch of Real-Time Variant Tracker",
        "urgency": 0.7
      }
    ],
    "posted_date": "2026-11-12T18:21:44.330Z",
    "num_comments": 0
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.